Skip to main content
SpringerLink
Log in

Seasonal Allergic Rhinitis

Newer Treatment Approaches

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Improved treatment approaches for seasonal allergic rhinitis are based on the increasing knowledge about allergic inflammation and on the improved efficacy of newer drugs. The current management concept includes an individualised composition of the different approaches including allergen avoidance, topical treatment and the use of systemic drugs and specific immunotherapy.

Allergen avoidance, supported by pollen information, leads to a remarkable reduction of daily challenge situations. There is an increasing trend towards topical use of corticosteroids (e.g. budesonide and fluticasone) and mast cell stabilisers [e.g. sodium cromoglycate (cromolyn sodium), nedocromil and isospaglumic acid (N-acetylaspartylglutamic acid)] because of the potency of these drugs to impair the destructive activity of allergic inflammation.

Potent histamine H1-receptor antagonists (e.g. azelastine and levocabastine) are approved for local treatment and lead to prompt relief of troublesome symptoms. A new generation of orally active antihistamines (e.g. astemizole, cetirizine, loratadine and terfenadine) have tended to be called ‘antiallergics’ because of activity other than H1-blockade. Furthermore, these newer compounds are less likely to cause sedation.

Immunotherapy is still an integrated component in the treatment strategy. Standardised allergen extracts of high quality raise the treatment efficacy and safety.

Overall, forming an individual combination of treatment approaches gives the best result.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andri L, Senna GE, Betteli C, Andri G, Scaricabarozzi I, et al. Use of nimesulide in allergic rhinitis: preliminary results. Abstract. Schweizerische Medizinische Wochenschrift 121 (Suppl. 40/II): P2 047, 19, 1991

    Google Scholar 

  • Billah MM, Gilchrest HG, Eckel SP, Granzow CA, Lawton PJ, et al. Differential plasma duration of antiplatelet-activating factors and antihistamine activities of oral Sch 37370 in humans. Clinical Pharmacology and Therapeutics 52: 151–159, 1992

    Article  PubMed  CAS  Google Scholar 

  • Billah MM, Chapman RW, Watnick AS, Egan RW, Siegel MI, et al. Sch 37370: a new drug combining antagonism of platelet-activating factor (PAF) with antagonism of histamine. Agents and Actions 34 (Suppl.): 313–321, 1991

    PubMed  CAS  Google Scholar 

  • Borum P, Larsen FS. Seasonal allergic rhinitis treated with a beta-2-adrenostimulant. Allergy 42: 141–145, 1987

    Article  PubMed  CAS  Google Scholar 

  • Bousquet J, Hejjaoui A, Michel FB. Specific immunotherapy in asthma. Journal of Allergy and Clinical Immunology 86: 292–305, 1990

    Article  PubMed  CAS  Google Scholar 

  • Breiteneder H, Pettenburger K, Bito A, Kraft D, Rumpold H, et al. The gene coding for the major birch allergen, Bet v I, is highly homologous to a pea disease resistance response gene. EMBO Journal 8: 1935–1938, 1989

    PubMed  CAS  Google Scholar 

  • Brogden RN, Me Tavish D. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders. Drugs 41: 927–940, 1991

    Article  PubMed  CAS  Google Scholar 

  • Brunet C, Bedard PM, Lavoie A, Jobin M, Herbert J. Allergic rhinitis to ragweed pollen. I. Reassessment of the effects of immunotherapy on cellular and humoral responses. Journal of Allergy and Clinical Immunology 89: 76–86, 1992

    Article  PubMed  CAS  Google Scholar 

  • Bryson HM, Faulds D. Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 43: 760–775, 1992

    Article  PubMed  CAS  Google Scholar 

  • Busse WW, Orr TSC, Pauwels R (Eds). International symposium on nedocromil sodium. Drugs 37; (Suppl. 1) (1–137): 1989

    Article  Google Scholar 

  • Dechant KL, Goa KL. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 41: 202–224, 1991

    Article  PubMed  CAS  Google Scholar 

  • De Clerck F, Van Glabbeek G, Somers, Y. Astemizole inhibits PAF-induced bronchoconstriction in vivo in guinea-pigs by antagonizing effects of locally released histamine. Abstract. Allergy and Clinical Immunology News (Suppl. 1): 292, 1991

    Google Scholar 

  • Ghaem A. A preliminary evaluation of the effect of Nacetyl-as-partyl-glutamate on pollen nasal challenge as measured by rhi-nomanometry and symptomatology. Allergy 42: 626–630, 1987

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez JP, Brogden RN. Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstruction airways disease. Drugs 43: 560–577, 1987

    Article  Google Scholar 

  • Greenbaum J, Leznoff A, Schulz J, Mazza J, Tobe A, et al. Comparative tolerability of two formulations of Rhinalar (fluni-solide) nasal spray in patients with seasonal allergic rhinitis. Annals of Allergy 61: 305–310, 1988

    PubMed  CAS  Google Scholar 

  • Haidvogl M. Alternative treatment possibilities of atopic diseases. Pädiatric Pathology 25: 389–396, 1990

    CAS  Google Scholar 

  • Holgate ST, Goa KL, Horak F, Knight A, Möller C (Eds). Astemizole — a review of clinical experience, pp. 1–82, Adis Press, Manchester, 1988

    Google Scholar 

  • Horak F. Budesonid und Beclomethasondipropionat in der Behandlung der allergischen Rhinitis — Eine vergleichende Untersuchung, HNO Nachrichten, München 73: 1852–1856, 1987

    Google Scholar 

  • Horak F. Results of the Vienna provocation study: onset of action of intranasal and oral azelastine in pollen-induced allergic rhinitis. Abstract. Allergy 47 (Suppl.): 6–7, 1992

    Article  Google Scholar 

  • Horak F, Jäger S, Andresen I. Dose finding of dimethindene maleat in pollinosis — as a new galenic formula. Abstract. Schweizerische Medizinische Wochenschrift 121 (Suppl. 40/II): P2 023, 13, 1991

    Google Scholar 

  • Horak F, Jäger S, Berger U. A new approach to estimate efficacy of local nasal immunotherapy. Notiziario Allergologico 9: 189–198, 1990

    Google Scholar 

  • Horak F, Jäger S, Berger U. Onset and duration of the effects of three antihistamines in current use — astemizole, loratadine and terfenadine forte — studied during prolonged, controlled allergen challenges in volunteers. Journal of International Medical Research 20: 422–434, 1992a

    PubMed  CAS  Google Scholar 

  • Horak F, Matthes H. The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled doubleblind, crossover study. Annals of Allergy 48: 305–308, 1982

    PubMed  CAS  Google Scholar 

  • Horak F, Toth J, Jäger J, Berger U. Effect of H1-receptor antagonists on nasal obstruction in atopic patients. Allergy 47: in press, 1992b

  • Horak F, Wheeler AW. Oral hyposensitization with enteric-coated allergens as extension therapy following a basic subcutaneous course of injections. International Archives of Allergy and Applied Immunology 84: 74–78, 1987

    Article  PubMed  CAS  Google Scholar 

  • Hömberg K, Pipkorn U, Bake B, Blychert LO. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reaction in patients with allergic rhinitis. Allergy 44: 281–287, 1989

    Article  Google Scholar 

  • Jäger S. EANS — European Aeroallergen Network Server. Aero-biologia 4: 16–19, 1988

    Google Scholar 

  • Jalkut SI, Gulling EV. Vilosen — is a new antiallergic preparation. Abstract. Allergy 47 (Suppl. 12): 173, 1992

    Google Scholar 

  • Kaulbach HC, Igarashi Y, Mullol J, White MV, Kaliner MA. Effects of nedocromil sodium on allergen-induced rhinitis in humans. Journal of Allergy and Clinical Immunology 89: 599–610, 1992

    Article  PubMed  CAS  Google Scholar 

  • Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW. Clinical and immunological follow-up of patients who stop venom immunotherapy. Journal of Allergy and Clinical Immunology 88: 339–348, 1991

    Article  PubMed  CAS  Google Scholar 

  • Knight A, Drouin M, Yang W, Alexander M, Del Carpio J, et al. Clinical evaluation of efficacy and safety of noberastine, a new H1 antagonist, in seasonal allergic rhinitis: a placebo-controlled, dose-response study. Journal of Allergy and Clinical Immunology 88: 926–934, 1991

    Article  PubMed  CAS  Google Scholar 

  • Leggieri E, Tedeschi A, Lorini M, Bianco A, Miadonna A. Study of the effects of paf-acether on human nasal airways. Allergy 46: 466–471, 1991

    PubMed  CAS  Google Scholar 

  • Liu WL, Pearce FL, Theraulaz-Lacroix M, Towart R. Mast-cell stabilising effects of dimethindene maleate (fenistil) and its optical isomers. Abstract. Schweizerische Medizinische Wochenschrift 121 (Suppl. 40/II): P2 009, 10, 1991

    Google Scholar 

  • Machiels JJ, Somville MA, Jacquemin MG, Saint-Remy JM. Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergen-antibody complex immunotherapy. Allergy 46: 335–348, 1991

    Article  PubMed  CAS  Google Scholar 

  • Majchel AM, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clinical and Experimental Allergy 20: 701–705, 1990

    Article  PubMed  CAS  Google Scholar 

  • Mailing HJ, Weeke B. EAACI immunotherapy position paper, 1992 revised version. Allergy 47 (Suppl.): in press, 1992

  • McTavish D, Goa KL, Ferrill M. Terfenadine: an update review of its pharmacological properties and therapeutic efficacy. Drugs 39: 552–551, 1990

    Article  PubMed  CAS  Google Scholar 

  • McTavish D, Sorkin EM. Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 38: 778–800, 1989

    Article  PubMed  CAS  Google Scholar 

  • Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment?. Allergy 43: 523–529, 1988

    Article  PubMed  CAS  Google Scholar 

  • Nathan RA, Bronsky EA, Fireman P, Grossman J, La Force CF, et al. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Annals of Allergy 67: 332–338, 1991

    PubMed  CAS  Google Scholar 

  • Ophir D, Elad Y, Dolev Z, Geller-Bernstein C. Effects of inhaled humidified warm air on nasal patency and nasal symptoms in allergic rhinitis. Annals of Allergy 60: 239–242, 1988

    PubMed  CAS  Google Scholar 

  • Pipkorn U, Granerus G, Proud D, Kagey-Sobotka A, Norman PS, et al. The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction. Allergy 42: 496–501, 1987

    Article  PubMed  CAS  Google Scholar 

  • Rosenzweig P, Thebault JJ, Caplain H, Dubruc C, Bianchetti G, et al. Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine. Annals of Allergy 69: 135–139, 1992

    PubMed  CAS  Google Scholar 

  • Scheiner O, Bohle B, Breitenbach M, Breiteneder H, Duchene M, et al. Recombinant allergens: production and possible clinical implications. In Godard et al. (Eds) Advances in allergology and clinical immunology, pp. 115–126, Parthenon Publishing Group, Lancs. (UK) and New Jersey (USA), 1992

    Google Scholar 

  • Taudorf E, Laursen LC, Lanner A, Bjorksten B, Dreborg S, et al. Oral immunotherapy in birch pollen hay fever. Journal of Allergy and Clinical Immunology 80: 153–161, 1987

    Article  PubMed  CAS  Google Scholar 

  • Tinkelman D, Falliers C, Gross G, Segal A, Southern L, et al. Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis. Annals of Allergy 64: 234–240, 1990

    PubMed  CAS  Google Scholar 

  • Vanzieleghem MA, Juniper EF. A comparison of budesonide and beclomethasone dipropionate nasal aerosols in ragweedin-duced rhinitis. Journal of Allergy and Clinical Immunology 79: 887–892, 1987

    Article  PubMed  CAS  Google Scholar 

  • Walsh GM, Moqbel R, Hartneil A, Kay AB. Effects of cetirizine on human eosinophil and neutrophil activation in vitro. International Archives of Allergy and Applied Immunology 95: 158–162, 1991

    Article  PubMed  CAS  Google Scholar 

  • Yakatan G, Dennis S, Prenner B, Rangus K, Wold R. Pentigetide: efficacy in patients with allergic rhinitis. Abstract. Allergy Proceedings 9: 372, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ENT-University Clinic Vienna, AKH, Währinger Gürtel 18, A-1090, Vienna, Austria

    Friedrich Horak

Authors
  1. Friedrich Horak
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horak, F. Seasonal Allergic Rhinitis. Drugs 45, 518–527 (1993). https://doi.org/10.2165/00003495-199345040-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199345040-00004

Keywords

Search

Navigation